Wang Ziyan, Yan Chunhong
GRU Cancer Center.
GRU Cancer Center; Department of Biochemistry and Molecular Biology; Medical College of Georgia; Georgia Regents University; Augusta, GA USA.
Mol Cell Oncol. 2015 Feb 3;3(1):e1010948. doi: 10.1080/23723556.2015.1010948. eCollection 2016 Jan.
Stress response mediator activating transcription factor 3 (ATF3) engages in diverse oncogenic pathways including the androgen receptor signaling essential for prostatic proliferation. In line with frequent downregulation of ATF3 expression in human prostate cancers, we have provided the first genetic evidence supporting the role of ATF3 as a tumor suppressor in a subset of prostate cancers with PTEN dysfunction.
应激反应介质激活转录因子3(ATF3)参与多种致癌途径,包括对前列腺增殖至关重要的雄激素受体信号传导。鉴于ATF3在人类前列腺癌中经常下调,我们提供了首个遗传学证据,支持ATF3在一部分具有PTEN功能障碍的前列腺癌中作为肿瘤抑制因子的作用。